PRAVATO, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 1.061
AS - Asia 381
EU - Europa 317
SA - Sud America 99
AF - Africa 87
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 6
Totale 1.965
Nazione #
US - Stati Uniti d'America 1.020
SG - Singapore 129
CN - Cina 88
IT - Italia 79
HK - Hong Kong 74
BR - Brasile 67
DE - Germania 43
FI - Finlandia 25
GB - Regno Unito 21
NL - Olanda 20
PL - Polonia 19
SE - Svezia 19
CI - Costa d'Avorio 17
FR - Francia 15
RU - Federazione Russa 15
VN - Vietnam 14
AT - Austria 12
AR - Argentina 8
IN - India 7
BD - Bangladesh 6
ES - Italia 6
MX - Messico 6
UG - Uganda 6
BO - Bolivia 5
CA - Canada 5
IE - Irlanda 5
MA - Marocco 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
BW - Botswana 4
CO - Colombia 4
HN - Honduras 4
ID - Indonesia 4
MY - Malesia 4
NZ - Nuova Zelanda 4
PA - Panama 4
SN - Senegal 4
AU - Australia 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BE - Belgio 3
BY - Bielorussia 3
CD - Congo 3
CG - Congo 3
CH - Svizzera 3
CV - Capo Verde 3
EC - Ecuador 3
GF - Guiana Francese 3
GN - Guinea 3
HU - Ungheria 3
IR - Iran 3
JM - Giamaica 3
LV - Lettonia 3
MU - Mauritius 3
NC - Nuova Caledonia 3
NG - Nigeria 3
NP - Nepal 3
SA - Arabia Saudita 3
SI - Slovenia 3
TR - Turchia 3
UZ - Uzbekistan 3
VE - Venezuela 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
AO - Angola 2
BS - Bahamas 2
CW - ???statistics.table.value.countryCode.CW??? 2
DJ - Gibuti 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GP - Guadalupe 2
GT - Guatemala 2
IQ - Iraq 2
JO - Giordania 2
JP - Giappone 2
KH - Cambogia 2
KR - Corea 2
KY - Cayman, isole 2
LB - Libano 2
ME - Montenegro 2
MN - Mongolia 2
PE - Perù 2
PF - Polinesia Francese 2
PS - Palestinian Territory 2
PY - Paraguay 2
RE - Reunion 2
RO - Romania 2
RS - Serbia 2
RW - Ruanda 2
UY - Uruguay 2
WS - Samoa 2
YT - Mayotte 2
AF - Afghanistan, Repubblica islamica di 1
BF - Burkina Faso 1
BG - Bulgaria 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
Totale 1.920
Città #
Fairfield 158
Ashburn 129
Singapore 82
Chandler 72
Hong Kong 72
Cambridge 61
Seattle 52
Woodbridge 48
Houston 44
Ann Arbor 34
Santa Clara 33
Beijing 27
Wilmington 27
Los Angeles 25
San Diego 24
Munich 22
Chicago 21
Boardman 20
Padova 19
Abidjan 17
Helsinki 17
New York 12
Salt Lake City 12
Bytom 11
Guangzhou 11
Medford 11
Princeton 11
Dallas 8
London 8
Elk Grove Village 6
Kampala 6
Vienna 6
Des Moines 5
Düsseldorf 5
Rio de Janeiro 5
Amsterdam 4
Buffalo 4
Dakar 4
Falkenstein 4
Gaborone 4
Nuremberg 4
Panama City 4
Pignone 4
Roxbury 4
Sterling 4
Warsaw 4
Auckland 3
Baku 3
Belo Horizonte 3
Bridgetown 3
Conakry 3
Curitiba 3
Detroit 3
Dublin 3
Frankfurt am Main 3
Hebei 3
Hefei 3
Ho Chi Minh City 3
Lancaster 3
Lappeenranta 3
Ljubljana 3
Madrid 3
Milan 3
Minsk 3
Montreal 3
Nanjing 3
Noale 3
Noumea 3
Riga 3
São Paulo 3
Tampa 3
Tianjin 3
Turku 3
Amman 2
Aparecida de Goiânia 2
Apia 2
Atlanta 2
Biên Hòa 2
Brasília 2
Brooklyn 2
Brussels 2
Buenos Aires 2
Casablanca 2
Charlotte 2
Criciúma 2
Denver 2
Ferizaj 2
Forlì 2
George Town 2
Hangzhou 2
Hanoi 2
Jinan 2
Kigali 2
Kingston 2
Kuala Lumpur 2
La Paz 2
Lagos 2
Lima 2
Luanda 2
Mamoudzou 2
Totale 1.300
Nome #
Prognostic and Predictive Effect of IGHV Mutational Status and Load in Chronic Lymphocytic Leukemia: Focus on FCR and BR Treatments 184
The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia 175
BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome 174
Enlarged Virchow Robin spaces associate with cognitive decline in multiple sclerosis 167
Lights and Shade of Next-Generation Pi3k Inhibitors in Chronic Lymphocytic Leukemia 163
Ibrutinib in relapsed hairy cell leukemia variant: a case report and review of the literature 152
Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi 149
Dabigatran in ibrutinib-treated patients with atrial fibrillation and lymphoproliferative diseases: Experience of 4 cases 147
Targeting of HSP70/HSF1 Axis Abrogates In Vitro Ibrutinib-Resistance in Chronic Lymphocytic Leukemia 140
From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance 121
Continous Treatment with Ibrutinib in 100 Untreated Patients with TP53 Disrupted Chronic Lymphocytic Leukemia. A Real‐Life Campus CLL Study 102
Focal adhesion kinase activation by calcium-dependent calpain is involved in chronic lymphocytic leukaemia cell aggressiveness 80
Anaemia during venetoclax ramp-up phase: Do not forget unusual causes 76
Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies 72
A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency 62
Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study 47
Totale 2.011
Categoria #
all - tutte 8.150
article - articoli 8.150
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.300


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021173 0 0 5 80 3 5 7 12 21 13 20 7
2021/2022222 16 17 9 4 23 25 10 21 39 11 17 30
2022/2023153 25 11 1 17 24 21 0 8 10 5 20 11
2023/2024134 8 21 10 14 18 19 9 4 1 14 9 7
2024/2025577 0 34 27 18 53 22 23 43 51 30 88 188
2025/2026485 147 149 189 0 0 0 0 0 0 0 0 0
Totale 2.011